Co-Diagnostics shareholders elect all five director nominees, approve 2025 equity plan

Co-Diagnostics, Inc.

Dwight Egan, Eugene Durenard, Richard Serbin, James Nelson, and Eward Murphy each elected with >10.2M votes for.
2025 Equity Incentive Plan approved with 10,676,931 for, 2,761,398 against, 61,338 abstain.
Advisory vote on executive compensation passed with 11,042,215 for, 2,296,490 against.
Ratification of Tanner LLC as auditor for 2025 approved with 16,724,962 for, 803,028 against.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.